Digital gastrointestinal well being firm Vivante Health introduced it closed a $31 million Sequence B funding spherical led by new investor Mercato Companions, bringing its whole elevate to $47 million.
Well being Catalyst, Intermountain Ventures, SemperVirens, 7wireVentures, Human Capital and Distributed Ventures participated within the spherical.
WHAT IT DOES
Vivante provides a platform dubbed GIThrive that gives customized care plans. Sufferers can monitor their signs and entry instructional content material and self-guided behavioral well being modules. A coordinated staff of suppliers can be obtainable by way of the platform, together with dietitians, coaches and well being physicians.
The Illinois-based firm will use the funding to improve its expertise and broaden its workforce.
“We’re thrilled to have the assist of industry-leading capital companions as we execute on our imaginative and prescient at Vivante,” Invoice Snyder, Vivante Well being CEO, stated in a press release. “One in 4 People suffers from a digestive dysfunction or undiagnosed digestive signs that have an effect on their high quality of life in addition to their healthcare prices. We have now confirmed that our scalable expertise platform paired with our complete care staff ends in higher well being, decrease prices and a significantly better expertise for the members we serve.”
MARKET SNAPSHOT
Vivante raised $16 million in Series A funding final 12 months, $5.8 million in Series A1 investment in 2020 and $6 million in 2018.
In 2022, Solera Health, a digital platform that gives a market for advantages and continual illness administration applications, announced it was adding Vivante and fellow digital gastrointestinal well being firm Oshi Health to its market of advantages and continual care administration instruments.
Different corporations within the digital gastrointestinal house embrace Salvo Health, which provides a digital clinic geared towards folks with continual intestine issues corresponding to irritable bowel syndrome, and Bold Health, a London-based firm creating digital therapeutics for gastrointestinal situations.
